Biohaven Pharmaceuticals (United States)
- World rank, 2022–2025
- #23,492 of 28,054 · #36,546 all time
- Rank in United States
- #3,520 of 4,192
- Research works
- 131 ▲ 4685% vs 2013–17
- Citations
- 4.8k 36.7 per fractional work
- Top-10% rate
- 12.2% record average 16.5%
- Open access
- 29% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 9.2×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 9.2×
- Neuroscience 7.2×
- Medicine 3.0×
- Chemistry 2.6×
- Nursing 1.5×
- Immunology and Microbiology 1.4×
- Biochemistry, Genetics and Molecular Biology 1.4×
- Psychology 1.2×
- Health Professions 0.6×
- Economics, Econometrics and Finance 0.3×
- Energy 0.3×
- Computer Science 0.2×
- Social Sciences 0.2×
- Engineering 0.2×
- Materials Science 0.1×
- Physics and Astronomy 0.1×
- Environmental Science 0.0×
- Arts and Humanities 0.0×
Who are the top researchers at Biohaven Pharmaceuticals (United States)?
Ranked on the composite score, Gilbert L’Italien, Bruce D. Car and Robert Croop lead among researchers whose main affiliation is Biohaven Pharmaceuticals (United States).
- 1 Gilbert L’Italien United States · #315,773 worldwide 136 citations · 45 works
- 2 Bruce D. Car United States · #625,550 worldwide 46 citations · 17 works
- 3 Robert Croop United States · #862,429 worldwide 12 citations · 21 works
- 4 Richard Bertz United States · #1,007,472 worldwide 12 citations · 20 works
- 5 Vladimir Coric United States · #1,316,292 worldwide 11 citations · 23 works
- 6 Vlad Coric United States · #1,444,664 worldwide 2 citations · 19 works
- 7 Alexandra Thiry United States · #1,536,577 worldwide 7 citations · 16 works
- 8 Irfan Qureshi United States · #1,540,885 worldwide 17 citations · 24 works
- 9 Michele Potashman United States · #1,548,978 worldwide 12 citations · 16 works
Which keywords describe research at Biohaven Pharmaceuticals (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Neurological Disorders, Headache Disorders, Migraine, Mitochondrial Dysfunction, Oxidative Stress, Parkinson's Disease, Neurodegeneration and Diagnostic Criteria.
- Cognitive Function
- SMN1
- Nuclear Receptors
- ESD Protection
- Neuroprotection
- Cardiac Electrophysiology
- Epilepsy
- Arrhythmias
- Ion Channels
- Encephalopathy
- a-Synuclein
- Genetic Risk Factors
- Polyglutamine
- Protein Aggregation
- Quality of Life
- Diagnostic Criteria
- Inflammation
- Parkinson's Disease
- Mitochondrial Dysfunction
- Headache Disorders
- Neurological Disorders
- Migraine
- Oxidative Stress
- Neurodegeneration
- Treatment
- Dopaminergic Neurons
- Genetics
- Huntington's Disease
- Neurobiology
- Sudden Cardiac Death
- Alzheimer's Disease
- Stroke
- Antiepileptic Drugs
- Calcium Signaling
- Genetic Testing
- Long-QT Syndrome
- CMOS Technology
- Neuromuscular Junction
- Pharmacokinetics
- Spinal Muscular Atrophy
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Neurological Disorders13▲ 35×10 topics
- Headache Disorders10▲ 600×1 topic
- Migraine10▲ 351×1 topic
- Mitochondrial Dysfunction8▲ 38×7 topics
- Oxidative Stress7▲ 6.4×11 topics
- Parkinson's Disease4▲ 25×7 topics
- Neurodegeneration4▲ 20×6 topics
- Inflammation3▲ 2.2×11 topics
- Treatment3▲ 3.7×10 topics
- Diagnostic Criteria3▲ 20×4 topics
- Dopaminergic Neurons3▲ 68×2 topics
- Quality of Life3▲ 3.0×6 topics
- Genetics3▲ 5.7×8 topics
- Protein Aggregation3▲ 72×2 topics
- Huntington's Disease2▲ 119×1 topic
- Polyglutamine2▲ 119×1 topic
- Neurobiology2▲ 13×7 topics
- Genetic Risk Factors2▲ 62×1 topic
- Sudden Cardiac Death2▲ 39×2 topics
- a-Synuclein2▲ 62×1 topic
- Alzheimer's Disease2▲ 11×4 topics
- Encephalopathy2▲ 45×2 topics
- Stroke2▲ 17×2 topics
- Ion Channels2▲ 27×3 topics
- Antiepileptic Drugs2▲ 34×2 topics
- Arrhythmias2▲ 28×2 topics
- Calcium Signaling2▲ 37×2 topics
- Epilepsy2▲ 24×2 topics
- Genetic Testing2▲ 23×2 topics
- Cardiac Electrophysiology2▲ 58×1 topic
- Long-QT Syndrome2▲ 58×1 topic
- Neuroprotection2▲ 6.6×4 topics
- CMOS Technology2▲ 28×1 topic
- ESD Protection2▲ 177×1 topic
- Neuromuscular Junction2▲ 55×2 topics
- Nuclear Receptors2▲ 25×3 topics
- Pharmacokinetics2▲ 8.6×4 topics
- SMN12▲ 98×1 topic
- Spinal Muscular Atrophy2▲ 98×1 topic
- Cognitive Function1▲ 12×3 topics
Which research topics does Biohaven Pharmaceuticals (United States) publish most on?
By volume in 2022–2025: Migraine and Headache Studies, Genetic Neurodegenerative Diseases, Parkinson's Disease Mechanisms and Treatments and Cardiac electrophysiology and arrhythmias.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Migraine and Headache Studies Psychiatry and Mental health 10 works
- 2 Genetic Neurodegenerative Diseases Cellular and Molecular Neuroscience 2 works
- 3 Parkinson's Disease Mechanisms and Treatments Neurology 2 works
- 4 Cardiac electrophysiology and arrhythmias Cardiology and Cardiovascular Medicine 2 works
- 5 Electrostatic Discharge in Electronics Electrical and Electronic Engineering 2 works
- 6 Neurogenetic and Muscular Disorders Research Genetics 2 works
- 7 Olfactory and Sensory Function Studies Sensory Systems 1 works
- 8 Epilepsy research and treatment Psychiatry and Mental health 1 works
- 9 Pharmacogenetics and Drug Metabolism Pharmacology 1 works
- 10 Neurological Complications and Syndromes Psychiatry and Mental health 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Biohaven Pharmaceuticals (United States)'s research output changed?
Output in 2018–2022 was 4685% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in New Haven
- Yale University
- Yale New Haven Hospital
- Yale Cancer Center
- Southern Connecticut State University
- Connecticut Agricultural Experiment Station
- Haskins Laboratories
- Yale New Haven Health System
- Connecticut Mental Health Center
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.